CERENO SCIENTIFIC AB B (F:4A1) — Stock Price

€0.43 EUR
▲ 1.14% today

CERENO SCIENTIFIC AB B (F:4A1) is currently trading at €0.43 EUR, up 1.14% today. Over the past 52 weeks, shares have ranged between €0.39 and €0.91. This page tracks CERENO SCIENTIFIC AB B's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 4A1 market cap.

CERENO SCIENTIFIC AB B (4A1) Stock Price Chart — Daily History & Trading Volume

The chart below tracks CERENO SCIENTIFIC AB B's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

CERENO SCIENTIFIC AB B Income Statement — Revenue, Profit & Earnings by Year

CERENO SCIENTIFIC AB B's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €0.00 €0.00 €0.00 €0.00 €0.00
Cost of Revenue €-44.27 Million €-80.90 Million €-49.28 Million €-57.54 Million €-44.81 Million
Gross Profit €44.27 Million €80.90 Million €49.28 Million €57.54 Million €44.81 Million
Research & Development
SG&A €76.44 Million €57.62 Million
Total Operating Expenses €74.60 Million €75.84 Million €44.24 Million €26.60 Million €14.78 Million
Operating Income €-74.60 Million €-75.84 Million €-44.24 Million €-26.60 Million €-14.78 Million
EBITDA
EBIT
Interest Expense €44.55 Million €26.09 Million €5.30 Million €459.07K €1.25 Million
Income Before Tax €-117.75 Million €-99.53 Million €-48.11 Million €-27.65 Million €-16.25 Million
Income Tax Expense
Net Income €-117.75 Million €-99.53 Million €-48.11 Million €-27.65 Million €-16.25 Million

CERENO SCIENTIFIC AB B Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes CERENO SCIENTIFIC AB B's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €402.67 Million €413.77 Million €284.99 Million €215.65 Million €180.74 Million
Total Current Assets €78.35 Million €133.00 Million €88.70 Million €68.63 Million €91.24 Million
Cash & Equivalents
Short-term Investments
Net Receivables
Inventory
Property, Plant & Equipment
Goodwill
Total Liabilities €150.20 Million €221.85 Million €68.56 Million €14.14 Million €10.67 Million
Total Current Liabilities €25.20 Million €31.45 Million €23.16 Million €13.74 Million €10.27 Million
Long-term Debt €125.00 Million €190.40 Million €45.40 Million €400.00K €400.00K
Net Debt €50.36 Million €62.82 Million
Total Stockholder Equity €252.47 Million €191.93 Million €216.42 Million €201.51 Million €170.06 Million
Retained Earnings €-57.97 Million €-30.22 Million

CERENO SCIENTIFIC AB B Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how CERENO SCIENTIFIC AB B generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-111.86 Million €-103.42 Million €-36.92 Million €-18.62 Million €-13.14 Million
Capital Expenditures €44.34 Million €84.77 Million €49.28 Million €57.54 Million €44.81 Million
Free Cash Flow €-156.21 Million €-188.20 Million €-86.19 Million €-76.15 Million €-57.94 Million
Investing Cash Flow
Financing Cash Flow
Dividends Paid
Stock-Based Compensation €1.42 Million €1.67 Million
Depreciation €787.89K €286.94K €14.31K €14.31K €14.31K
Change in Cash €-52.94 Million €40.41 Million €20.12 Million €-22.59 Million €23.63 Million

CERENO SCIENTIFIC AB B Earnings History — EPS Actual vs. Analyst Estimates

Track CERENO SCIENTIFIC AB B's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 27, 2026
Feb 27, 2026
Nov 27, 2025
Aug 27, 2025
May 22, 2025